Medpace Holdings, Inc. (MEDP)

Overview

Medpace Holdings, Inc., founded in 1992 and headquartered in Cincinnati, Ohio, is a key player in the provision of comprehensive clinical research services for the development of drugs and medical devices. Spanning its operations across North America, Europe, and Asia, the company supports pharmaceutical, biotechnology, and medical device industries through the entire clinical development process, from Phase I to Phase IV, across a wide range of therapeutic areas. Its aim is to facilitate the journey of bringing new and innovative treatments to market efficiently and effectively.

Products and Services

• Development Plan Design: Crafting bespoke development strategies addressing specific therapeutic area requirements and regulatory landscapes to streamline the development process from concept to market.
• Coordinated Central Laboratory: Offering centralized lab services that reduce logistical complexities, enhance data quality, and streamline sample management across global trial sites.
• Project Management: Delivering comprehensive project oversight to ensure milestones are met on time and within budget while maintaining adherence to regulatory standards.
• Regulatory Affairs: Providing expertise in navigating the complex regulatory environment to facilitate timely approval from regulatory bodies.
• Clinical Monitoring: Ensuring the integrity of clinical trial data through close site monitoring, including site selection, training, and ongoing assessment for adherence to protocols.
• Data Management and Analysis: Implementing rigorous processes for data collection, validation, and analysis to support statistical significance and findings of clinical trials.
• Pharmacovigilance: Monitoring and managing the safety profile of drugs through all phases of clinical trials to ensure patient safety and regulatory compliance.
• New Drug Application Submissions: Assisting in the preparation and submission of documentation required for the approval of new drugs, ensuring accuracy and regulatory compliance.
• Post-Marketing Clinical Support: Offering services to monitor a drug's performance and safety after it has been approved and is in the market to fulfill post-marketing requirements and commitments.
• Bio-Analytical Laboratory Services: Providing state-of-the-art laboratory services to support the analysis of biological samples, which is crucial for understanding the pharmacokinetics and pharmacodynamics of a drug.
• Clinical Human Pharmacology: Conducting early phase clinical trials, including first-in-human studies, to assess the safety, tolerability, and pharmacokinetics of a drug.
• Imaging Services: Utilizing advanced imaging technologies to enhance understanding of a drug's mechanism of action and contribute to endpoint assessments in clinical trials.
• Electrocardiography (ECG) Reading Support: Offering expert ECG analysis to detect potential cardiac risks in clinical trial participants, enhancing patient safety throughout the trial process.